Point72 Hong Kong’s Regenxbio RGNX Stock Holding History

Point72 Hong Kong’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-400	Closed	-$2.86K	–	659
2025 Q1	$2.86K	Buy	+400	New	+$2.98K	﹤0.01%	453
2024 Q1	–	Sell	-6,700	Closed	-$120K	–	756
2023 Q4	$120K	Buy	+6,700	New	+$118K	0.01%	467
2022 Q4	–	Sell	-3,033	Closed	-$80K	–	1348
2022 Q3	$80K	Buy	+3,033	New	+$90K	﹤0.01%	1294
2022 Q2	–	Sell	-976	Closed	-$32K	–	2331
2022 Q1	$32K	Sell	976 -317	-25%	-$8.8K	﹤0.01%	1450
2021 Q4	$42K	Buy	+1,293	New	+$44K	﹤0.01%	1382
2021 Q3	–	Sell	-1,890	Closed	-$73K	–	2367
2021 Q2	$73K	Buy	+1,890	New	+$67.6K	﹤0.01%	1391
2020 Q1	–	Sell	-570	Closed	-$23K	–	1287
2019 Q4	$23K	Buy	+570	New	+$22.5K	0.01%	857
2019 Q1	–	Sell	-123	Closed	-$5K	–	1236
2018 Q4	$5K	Buy	+123	New	+$7.22K	﹤0.01%	632
2017 Q2	–	Sell	-918	Closed	-$18K	–	1003
2017 Q1	$18K	Buy	+918	New	+$17.7K	0.02%	423

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Point72 Hong Kong's RGNX Position: Q2 2025 in Review

Point72 Hong Kong sold out of Regenxbio (RGNX) in Q2 2025, closing a stake of 400 shares — an estimated $2.86K sold.

Point72 Hong Kong first reported a position in RGNX in Q1 2017 and held it in 9 quarters. The position peaked at $120K in Q4 2023. 159 funds tracked by Wall St. Rank hold RGNX as of Q2 2025.

Point72 Hong Kong reported no remaining Regenxbio position as of Q2 2025 after selling out during the quarter.
Point72 Hong Kong sold 400 Regenxbio shares in Q2 2025, an estimated $2.86K.
Point72 Hong Kong first reported a position in Regenxbio in Q1 2017 and held it in 9 quarters.
Point72 Hong Kong's Regenxbio position peaked at $120K in Q4 2023.
159 funds tracked by Wall St. Rank held Regenxbio as of Q2 2025.

Based on Point72 Hong Kong's 13F filing for Q2 2025, filed 14 Aug 2025.